<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30519018</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>01</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>01</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1178-2013</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <PubDate>
              <Year>2018</Year>
            </PubDate>
          </JournalIssue>
          <Title>International journal of nanomedicine</Title>
          <ISOAbbreviation>Int J Nanomedicine</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A review on nanosystems as an effective approach against infections of <i>Staphylococcus aureus</i>.</ArticleTitle>
        <Pagination>
          <StartPage>7333</StartPage>
          <EndPage>7347</EndPage>
          <MedlinePgn>7333-7347</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.2147/IJN.S169935</ELocationID>
        <Abstract>
          <AbstractText><i>Staphylococcus aureus</i> (<i>S. aureus</i>) is an important zoonotic bacteria and hazardous for the health of human beings and livestock globally. The characteristics like biofilm forming, facultative intracellular survival, and growing resistance of <i>S. aureus</i> pose a great challenge to its use in therapy. Nanoparticles are considered as a promising way to overcome the infections' therapeutic problems caused by <i>S. aureus</i>. In this paper, the present progress and challenges of nanoparticles in the treatment of <i>S. aureus</i> infection are focused on stepwise. First, the survival and infection mechanism of <i>S. aureus</i> are analyzed. Second, the treatment challenges posed by <i>S. aureus</i> are provided, which is followed by the third step including the advantages of nanoparticles in improving the penetration and accumulation ability of their payload antibiotics into cell, inhibiting <i>S. aureus</i> biofilm formation, and enhancing the antibacterial activity against resistant isolates. Finally, the challenges and future perspective of nanoparticles for <i>S. aureus</i> infection therapy are introduced. This review will help the readers to realize that the nanosystems can effectively fight against the <i>S. aureus</i> infection by inhibiting biofilm formation, enhancing intracellular delivery, and improving activity against methicillin-resistant <i>S. aureus</i> and small colony variant phenotypes as well as aim to help researchers looking for more efficient nano-systems to combat the <i>S. aureus</i> infections.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhou</LastName>
            <ForeName>Kaixiang</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei, China, snxsy1@126.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Chao</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei, China, snxsy1@126.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Dongmei</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pan</LastName>
            <ForeName>Yuanhu</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei, China, snxsy1@126.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tao</LastName>
            <ForeName>Yanfei</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qu</LastName>
            <ForeName>Wei</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Zhenli</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>National Reference Laboratory of Veterinary Drug Residues (HZAU) and MAO Key Laboratory for Detection of Veterinary Drug Residues, Wuhan, Hubei, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xiaofang</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Animal Husbandry and Veterinary Institute of Hebei Province, Baoding, Hebei, China, wangxiao.fang99@163.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xie</LastName>
            <ForeName>Shuyu</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>MOA Laboratory for Risk Assessment of Quality and Safety of Livestock and Poultry Products, Huazhong Agricultural University, Wuhan, Hubei, China, snxsy1@126.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Nanomedicine</MedlineTA>
        <NlmUniqueID>101263847</NlmUniqueID>
        <ISSNLinking>1176-9114</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018441" MajorTopicYN="N">Biofilms</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055624" MajorTopicYN="N">Methicillin-Resistant Staphylococcus aureus</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053758" MajorTopicYN="N">Nanoparticles</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013203" MajorTopicYN="N">Staphylococcal Infections</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Staphylococcus aureus</Keyword>
        <Keyword MajorTopicYN="N">antibiotics</Keyword>
        <Keyword MajorTopicYN="N">infection mechanism</Keyword>
        <Keyword MajorTopicYN="N">nanoparticles</Keyword>
        <Keyword MajorTopicYN="N">resistance</Keyword>
      </KeywordList>
      <CoiStatement>Disclosure The authors report no conflicts of interest in this work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>1</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30519018</ArticleId>
        <ArticleId IdType="pmc">PMC6233487</ArticleId>
        <ArticleId IdType="doi">10.2147/IJN.S169935</ArticleId>
        <ArticleId IdType="pii">ijn-13-7333</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001;344(1):11–16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11136954</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7(2):178–182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2631711</ArticleId>
            <ArticleId IdType="pubmed">11294701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rasmussen G, Monecke S, Brus O, Ehricht R, Söderquist B. Long term molecular epidemiology of methicillin-susceptible Staphylococcus aureus bacteremia isolates in Sweden. PLoS One. 2014;9(12):e114276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4257557</ArticleId>
            <ArticleId IdType="pubmed">25479442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Posadowska U, Brzychczy-Włoch M, Pamuła E, Perl TM, Cullen JJ, Wenzel RP. Gentamicin loaded PLGA nanoparticles as local drug delivery system for the osteomyelitis treatment. Acta Bioeng Biomech. 2015;17(3):41–48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26687562</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gordon RJ, Lowy FD. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2008;46(Suppl 5):S350–S359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2474459</ArticleId>
            <ArticleId IdType="pubmed">18462090</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conlon BP. Staphylococcus aureus chronic and relapsing infections: evidence of a role for persister cells. Bioessays. 2014;36(10):991–996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25100240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou J, Fang T, Wang Y. The controlled release of vancomycin in gelatin/β-TCP composite scaffolds. J Biomed Mater Res. 2012;100A(9):2295–2301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22499502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banbury MK. Experience in prevention of sternal wound infections in nasal carriers of Staphylococcus aureus. Surgery. 2003;134(5 Suppl):S18–S22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14647029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michael IO, Gabriel OE. Pattern of renal diseases in children in mid-western zone of Nigeria. Saudi J Kidney Dis Transpl. 2003;14(4):539–544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17657132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boucher HW, Talbot GH, Benjamin DK, et al.  10 x ′20 Progress– development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(12):1685–1694.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3707426</ArticleId>
            <ArticleId IdType="pubmed">23599308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jagielski T, Puacz E, Lisowski A, et al.  Short communication: antimicrobial susceptibility profiling and genotyping of Staphylococcus aureus isolates from bovine mastitis in Poland. J Dairy Sci. 2014;97(10):6122–6128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25087034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Melchior MB, Vaarkamp H, Fink-Gremmels J. Biofilms: a role in recurrent mastitis infections? Vet J. 2006;171(3):398–407.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16624706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Halasa T, Huijps K, Østerås O, Hogeveen H. Economic effects of bovine mastitis and mastitis management: a review. Vet Q. 2007;29(1):18–31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17471788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loiselle MC, Ster C, Talbot BG, et al.  Impact of postpartum milking frequency on the immune system and the blood metabolite concentration of dairy cows. J Dairy Sci. 2009;92(5):1900–1912.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19389948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clement S, Vaudaux P, Francois P, et al.  Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis. 2005;192(6):1023–1028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16107955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kerrn MB, Struve C, Blom J, Frimodt-Møller N, Krogfelt KA. Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice. J Antimicrob Chemother. 2005;55(3):383–386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15681580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monack DM, Mueller A, Falkow S. Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol. 2004;2(9):747–765.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15372085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freeman AF, Holland SM. Persistent bacterial infections and primary immune disorders. Curr Opin Microbiol. 2007;10(1):70–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17208513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prajsnar TK, Cunliffe VT, Foster SJ, Renshaw SA. A novel vertebrate model of Staphylococcus aureus infection reveals phagocyte-dependent resistance of zebrafish to non-host specialized pathogens. Cell Microbiol. 2008;10(11):2312–2325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18715285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Löffler B, Tuchscherr L, Niemann S, Peters G. Staphylococcus aureus persistence in non-professional phagocytes. Int J Med Microbiol. 2014;304(2):170–176.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24365645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Speziale P, Pietrocola G, Rindi S, et al.  Structural and functional role of Staphylococcus aureus surface components recognizing adhesive matrix molecules of the host. Future Microbiol. 2009;4(10):1337–1352.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19995192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zecconi A, Scali F. Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases. Immunol Lett. 2013;150(1–2):12–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23376548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clarke SR, Brummell KJ, Horsburgh MJ, et al.  Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. J Infect Dis. 2006;193(8):1098–1108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16544250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garzoni C, Kelley WL. Staphylococcus aureus: new evidence for intracellular persistence. Trends Microbiol. 2009;17(2):59–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19208480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foster TJ, Geoghegan JA, Ganesh VK, Höök M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol. 2014;12(1):49–62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5708296</ArticleId>
            <ArticleId IdType="pubmed">24336184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bank TL, Dosen A, Giese RF, Haase EM, Sojar HT. Atomic force spectroscopy evidence of non-specific adhesion of Aggregatibacter actino-mycetemcomitans. J Nanosci Nanotechnol. 2011;11(10):8450–8456.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22400208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harraghy N, Hussain M, Haggar A, et al.  The adhesive and immunomodulating properties of the multifunctional Staphylococcus aureus protein Eap. Microbiology. 2003;149(Pt 10):2701–2707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14523103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fraunholz M, Sinha B. Intracellular Staphylococcus aureus: live-in and let die. Front Cell Infect Microbiol. 2012;2:43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3417557</ArticleId>
            <ArticleId IdType="pubmed">22919634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torres VJ, Pishchany G, Humayun M, Schneewind O, Skaar EP. Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J Bacteriol. 2006;188(24):8421–8429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1698231</ArticleId>
            <ArticleId IdType="pubmed">17041042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rasmussen G, Monecke S, Brus O, Ehricht R, Söderquist B. Long term molecular epidemiology of methicillin-susceptible Staphylococcus aureus bacteremia isolates in Sweden. PLoS One. 2014;9(12):e114276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4257557</ArticleId>
            <ArticleId IdType="pubmed">25479442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilke GA, Bubeck Wardenburg J, Wardenburg JB. Role of a dis-integrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proc Natl Acad Sci U S A. 2010;107(30):13473–13478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2922128</ArticleId>
            <ArticleId IdType="pubmed">20624979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grosz M, Kolter J, Paprotka K, et al.  Cytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin α. Cell Microbiol. 2014;16(4):451–465.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3969633</ArticleId>
            <ArticleId IdType="pubmed">24164701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garzoni C, Kelley WL. Staphylococcus aureus: new evidence for intracellular persistence. Trends Microbiol. 2009;17(2):59–65.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19208480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kahl BC. Small colony variants (SCVs) of Staphylococcus aureus – a bacterial survival strategy. Infect Genet Evol. 2014;21:515–522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23722021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuchscherr L, Medina E, Hussain M, et al.  Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med. 2011;3(3):129–141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3395110</ArticleId>
            <ArticleId IdType="pubmed">21268281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuchscherr L, Geraci J, Löffler B. Staphylococcus aureus regulator Sigma B is important to develop chronic infections in hematogenous murine osteomyelitis model. Pathogens. 2017;6(3):E31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5617988</ArticleId>
            <ArticleId IdType="pubmed">28714889</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Proctor RA, Balwit JM, Vesga O. Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect Agents Dis. 1994;3(6):302–312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7889317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sendi P, Proctor RA. Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol. 2009;17(2):54–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19162480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bui LMG, Kidd SP. A full genomic characterization of the development of a stable small colony variant cell-type by a clinical Staphylococcus aureus strain. Infect Genet Evol. 2015;36:345–355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26458527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuchscherr L, Heitmann V, Hussain M, et al.  Staphylococcus aureus small-colony variants are adapted phenotypes for intracellular persistence. J Infect Dis. 2010;202(7):1031–1040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20715929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ou JJ, Drilling AJ, Cooksley C, et al.  Reduced innate immune response to a Staphylococcus aureus small colony variant compared to its wild-type parent strain. Front Cell Infect Microbiol. 2016;6:187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5183720</ArticleId>
            <ArticleId IdType="pubmed">28083514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Serra R, Grande R, Buffone G, et al.  Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines. Int Wound J. 2016;13(1):53–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24618232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Looney WJ. Small-colony variants of Staphylococcus aureus. Br J Biomed Sci. 2000;57(4):317–322.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11204864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Besier S, Ludwig A, Ohlsen K, Brade V, Wichelhaus TA. Molecular analysis of the thymidine-auxotrophic small colony variant phenotype of Staphylococcus aureus. Int J Med Microbiol. 2007;297(4):217–225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17412637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amato SM, Fazen CH, Henry TC, et al.  The role of metabolism in bacterial persistence. Front Microbiol. 2014;5:70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3939429</ArticleId>
            <ArticleId IdType="pubmed">24624123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bassegoda A, Ivanova K, Ramon E, Tzanov T. Strategies to prevent the occurrence of resistance against antibiotics by using advanced materials. Appl Microbiol Biotechnol. 2018;102(5):2075–2089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29392390</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oyama T, Miyazaki M, Yoshimura M, Takata T, Ohjimi H, Jimi S. Biofilm-forming methicillin-resistant Staphylococcus aureus survive in kupffer cells and exhibit high virulence in mice. Toxins. 2016;8(7):198.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4963831</ArticleId>
            <ArticleId IdType="pubmed">27376326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Armstead AL, Li B. Nanomedicine as an emerging approach against intracellular pathogens. Int J Nanomedicine. 2011;6:3281–3293.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3252676</ArticleId>
            <ArticleId IdType="pubmed">22228996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Limbert M, Isert D, Klesel N, et al.  Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1991;35(1):14–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC244934</ArticleId>
            <ArticleId IdType="pubmed">2014969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Briones E, Colino CI, Lanao JM. Delivery systems to increase the selectivity of antibiotics in phagocytic cells. J Control Release. 2008;125(3):210–227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18077047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinto-Alphandary H, Andremont A, Couvreur P. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int J Antimicrob Agents. 2000;13(3):155–168.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10724019</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taber WH, Mueller JP, Miller PF. Bacterial uptake of aminoglycoside antibiotics. Micro Rev. 1987;51(4):439–457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC373126</ArticleId>
            <ArticleId IdType="pubmed">3325794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bui LM, Conlon BP, Kidd SP. Antibiotic tolerance and the alternative lifestyles of Staphylococcus aureus. Essays Biochem. 2017;61(1):71–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28258231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gómez Casanova N, Siller Ruiz M, Muñoz Bellido JL. Mechanisms of resistance to daptomycin in Staphylococcus aureus. Rev Esp Quimioter. 2017;30(6):391–396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29082727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gardete S, Tomasz A. Mechanisms of vancomycin resistance in Staphylococcus aureus. J Clin Invest. 2014;124(7):2836–2840.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4071404</ArticleId>
            <ArticleId IdType="pubmed">24983424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Becker K, Ballhausen B, Köck R, Kriegeskorte A. Methicillin resistance in Staphylococcus isolates: the “mec alphabet” with specific consideration of mecC, a mec homolog associated with zoonotic S. aureus lineages. Int J Med Microbiol. 2014;304(7):794–804.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25034857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deurenberg RH, Stobberingh EE. The molecular evolution of hospital-and community-associated methicillin-resistant Staphylococcus aureus. Curr Mol Med. 2009;9(2):100–115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19275621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol. 2009;11(7):1034–1043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19374653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh R, Ray P, Das A, Sharma M. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J Med Microbiol. 2009;58(Pt 8):1067–1073.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19528167</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park SB, Steadman CS, Chaudhari AA, et al.  Proteomic analysis of antimicrobial effects of pegylated silver coated carbon nanotubes in Salmonella enterica serovar Typhimurium. J Nanobiotechnology. 2018;16(1):31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5870919</ArticleId>
            <ArticleId IdType="pubmed">29587743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yazar E, Bas AL, Birdane YO, Yapar K, Elmas M, Tras B. Determination of intracellular (neutrophil and monocyte) concentrations of free and liposome encapsulated ampicillin in sheep. Veterinární Medicína. 2012;51(2):51–54.</Citation>
        </Reference>
        <Reference>
          <Citation>Bastari K, Arshath M, Ng ZH, et al.  A controlled release of antibiotics from calcium phosphate-coated poly(lactic-co-glycolic acid) particles and their in vitro efficacy against Staphylococcus aureus biofilm. J Mater Sci Mater Med. 2014;25(3):747–757.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24370968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thomas N, Thorn C, Richter K, Thierry B, Prestidge C. Efficacy of poly-lactic-co-glycolic acid micro- and nanoparticles of ciprofloxacin against bacterial biofilms. J Pharm Sci. 2016;105(10):3115–3122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27519649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maya S, Indulekha S, Sukhithasri V, et al.  Efficacy of tetracycline encapsulated O-carboxymethyl chitosan nanoparticles against intracellular infections of Staphylococcus aureus. Int J Biol Macromol. 2012;51(4):392–399.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22705573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang XH, Zhou WM, He YZ, Wang Y, Lv B, Wang XM. Effects of lipopeptide carboxymethyl chitosan nanoparticles on Staphylococcus aureus biofilm. J Biol Regul Homeost Agents. 2017;31(3):737–743.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28956426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sutherland IW. The biofilm matrix – an immobilized but dynamic microbial environment. Trends Microbiol. 2001;9(5):222–227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11336839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou TH, Su M, Shang BC, et al.  Nano-hydroxyapatite/β-tricalcium phosphate ceramics scaffolds loaded with cationic liposomal ceftazidime: preparation, release characteristics in vitro and inhibition to Staphylococcus aureus biofilms. Drug Dev Ind Pharm. 2012;38(11):1298–1304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22257380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ranjan A, Pothayee N, Seleem MN. Antibacterial efficacy of core-shell nanostructures encapsulating gentamicin against an in vivo intracellular Salmonella model. Int J Nanomed. 2009;4:289–297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2802042</ArticleId>
            <ArticleId IdType="pubmed">20054433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ranjan A, Pothayee N, Vadala TP, et al.  Efficacy of amphiphilic core-shell nanostructures encapsulating gentamicin in an in vitro salmonella and listeria intracellular infection model. Antimicrob Agents Chemother. 2010;54(8):3524–3526.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2916305</ArticleId>
            <ArticleId IdType="pubmed">20516284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu D, Li H, Wang B, et al.  Surface-adaptive gold nanoparticles with effective adherence and enhanced photothermal ablation of methicillin-resistant Staphylococcus aureus biofilm. ACS Nano. 2017;11(9):9330–9339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28806528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alves MM, Bouchami O, Tavares A, et al.  New insights into antibiofilm effect of a nanosized ZnO coating against the pathogenic methicillin resistant Staphylococcus aureus. ACS Appl Mater Interfaces. 2017;9(34):28157–28167.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28782933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miller KP, Wang L, Chen YP, Pellechia PJ, Benicewicz BC, Decho AW. Engineering nanoparticles to silence bacterial communication. Front Microbiol. 2015;6:189.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4354405</ArticleId>
            <ArticleId IdType="pubmed">25806030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imbuluzqueta E. Drug delivery systems for potential treatment of intracellular bacterial infections. Front Biosci. 2010;15(1):397–417.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20036827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hua L, Hilliard JJ, Shi Y, et al.  Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother. 2014;58(2):1108–1117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3910899</ArticleId>
            <ArticleId IdType="pubmed">24295977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chakraborty SP, Sahu SK, Mahapatra SK, et al.  Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents. Nanotechnology. 2010;21(10):105103.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20154376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta PV, Nirwane AM, Belubbi T, Nagarsenker MS. Pulmonary delivery of synergistic combination of fluoroquinolone antibiotic complemented with proteolytic enzyme: a novel antimicrobial and antibiofilm strategy. Nanomedicine. 2017;13(7):2371–2384.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28648640</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsu CY, Yang SC, Sung CT, Weng YH, Fang JY. Anti-MRSA malleable liposomes carrying chloramphenicol for ameliorating hair follicle targeting. Int J Nanomedicine. 2017;12:8227–8238.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5689027</ArticleId>
            <ArticleId IdType="pubmed">29184410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pornpattananangkul D, Zhang L, Olson S, et al.  Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Am Chem Soc. 2011;133(11):4132–4139.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3062754</ArticleId>
            <ArticleId IdType="pubmed">21344925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dees C, Schultz RD. The mechanism of enhanced intraphagocytic killing of bacteria by liposomes containing antibiotics. Vet Immunol Immunopathol. 1990;24(2):135–146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2336788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ahani E, Montazer M, Toliyat T, Mahmoudi Rad M, Harifi T. Preparation of nano cationic liposome as carrier membrane for polyhexam-ethylene biguanide chloride through various methods utilizing higher antibacterial activities with low cell toxicity. J Microencapsul. 2017;34(2):121–131.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28609225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baş AL, Simşek A, Erganiş O, Corlu M, Bas AL, Simsek A. Efficacies of liposome-encapsulated enrofloxacin against Staphylococcus aureus infection in Anatolian shepherd dog monocytes in vitro. Dtsch Tierarztl Wochenschr. 2005;112(6):219–223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16028487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baş LA, Simşek A, Corlu M, Yazar E, Elmas M, Değim ZG. Determination of intracellular concentrations of free and two types of liposome-encapsulated enrofloxacin in anatolian shepherd dog monocytes. J Vet Med B Infect Dis Vet Public Health. 2002;49(6):289–293.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12241030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao G, Hu C, Xue Y. In vitro evaluation of chitosan-coated liposome containing both coenzyme Q10 and alpha-lipoic acid: cytotoxicity, antioxidant activity, and antimicrobial activity. J Cosmet Dermatol. 2018;17(2):258–262.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28722258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nigatu AS, Ashar H, Sethuraman SN, et al.  Elastin-like polypeptide incorporated thermally sensitive liposome improve antibiotic therapy against musculoskeletal bacterial pathogens. Int J Hyperthermia. 2018;34(2):201–208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29278945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie S, Yang F, Tao Y, et al.  Enhanced intracellular delivery and antibacterial efficacy of enrofloxacin-loaded docosanoic acid solid lipid nanoparticles against intracellular Salmonella. Sci Rep. 2017;7(1):4110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5253767</ArticleId>
            <ArticleId IdType="pubmed">28112240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uskoković V, Desai TA. Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus. Mater Sci Eng C Mater Biol Appl. 2014;37:210–222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3942787</ArticleId>
            <ArticleId IdType="pubmed">24582242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chou J, Valenzuela S, Green DW, et al.  Antibiotic delivery potential of nano- and micro-porous marine structure-derived β-tricalcium phosphate spheres for medical applications. Nanomedicine. 2014;9(8):1131–1139.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24471502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akbari V, Abedi D, Pardakhty A, Sadeghi-Aliabadi H. Ciprofloxacin nano-niosomes for targeting intracellular infections: an in vitro evaluation. J Nanopart Res. 2013;15(4):1–14.</Citation>
        </Reference>
        <Reference>
          <Citation>Geiser M. Update on macrophage clearance of inhaled micro- and nanoparticles. J Aerosol Med Pulm Drug Deliv. 2010;23(4):207–217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20109124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie S, Tao Y, Pan Y, et al.  Biodegradable nanoparticles for intracellular delivery of antimicrobial agents. J Control Release. 2014;187:101–117.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24878179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Genestet C, Bernard-Barret F, Hodille E, et al.  Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Myco-bacterium tuberculosis-infected macrophages. Tuberculosis (Edinb) 2018;111:67–70.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30029917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Release. 2010;145(3):182–195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2902597</ArticleId>
            <ArticleId IdType="pubmed">20226220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sémiramoth N, di Meo C, Zouhiri F, et al.  Self-assembled squalenoylated penicillin bioconjugates: an original approach for the treatment of intracellular infections. ACS Nano. 2012;6(5):3820–3831.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22482704</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allen TM, Austin GA, Chonn A, Lin L, Lee KC. Uptake of liposomes by cultured mouse bone marrow macrophages: influence of lipo-some composition and size. Biochim Biophys Acta. 1991;1061(1):56–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1995057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm Res. 2006;23(7):1417–1450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16779701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beningo KA, Wang Y. Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J Cell Sci. 2012;115:849–856.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11865040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalhapure RS, Sonawane SJ, Sikwal DR, et al.  Solid lipid nanoparticles of clotrimazole silver complex: an efficient nano antibacterial against Staphylococcus aureus and MRSA. Colloids Surf B Biointerfaces. 2015;136:651–658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26492156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalhapure RS, Mocktar C, Sikwal DR, et al.  Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles. Colloids Surf B Biointerfaces. 2014;117:303–311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24667076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li Y, Su T, Zhang Y, Huang X, Li J, Li C. Liposomal co-delivery of daptomycin and clarithromycin at an optimized ratio for treatment of methicillin-resistant Staphylococcus aureus infection. Drug Deliv. 2015;22(5):627–637.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24471983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Li Z, Wang X, et al.  Novel antimicrobial peptide-modified azithromycin-loaded liposomes against methicillin-resistant Staphylococcus aureus. Int J Nanomedicine. 2016;11:6781–6794.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5167457</ArticleId>
            <ArticleId IdType="pubmed">28008253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang D, Kong YY, Sun JH, et al.  Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance. Int J Nanomedicine. 2017;12:2081–2108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5360411</ArticleId>
            <ArticleId IdType="pubmed">28356731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalhapure RS, Jadhav M, Rambharose S, et al.  pH-responsive chitosan nanoparticles from a novel twin-chain anionic amphiphile for controlled and targeted delivery of vancomycin. Colloids Surf B Biointerfaces. 2017;158:650–657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28763772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalhapure RS, Sikwal DR, Rambharose S, et al.  Enhancing targeted antibiotic therapy via pH responsive solid lipid nanoparticles from an acid cleavable lipid. Nanomedicine. 2017;13(6):2067–2077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28434930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aurore V, Caldana F, Blanchard M, et al.  Silver-nanoparticles increase bactericidal activity and radical oxygen responses against bacterial pathogens in human osteoclasts. Nanomedicine. 2018;14(2):601–607.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29155361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richter K, Thomas N, Zhang G, et al.  Deferiprone and gallium- protoporphyrin have the capacity to potentiate the activity of antibiotics in Staphylococcus aureus small colony variants. Front Cell Infect Microbiol. 2017;7:280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5479885</ArticleId>
            <ArticleId IdType="pubmed">28690982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang XF, Zhang SL, Zhu LY, et al.  Enhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo. Vet J. 2012;191(1):115–120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21900026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie Y, Liu Y, Yang J. Gold nanoclusters for targeting MRSA in vivo. Angew Chem Int Ed Eng. 2018;57(15):3958–3962.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29423995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jadhav M, Kalhapure RS, Rambharose S, et al.  Novel lipids with three C18-fatty acid chains and an amino acid head group for pH-responsive and sustained antibiotic delivery. Chem Phys Lipids. 2018;212:12–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29305156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo J, Zhou H, Wang J, et al.  Nano vanadium dioxide films deposited on biomedical titanium: a novel approach for simultaneously enhanced osteogenic and antibacterial effects. Artif Cells Nanomed Biotechnol. 2018;21:1–17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29560740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao Z, Yan R, Yi X, et al.  Bacteria-activated theranostic nanoprobes against methicillin-resistant Staphylococcus aureus infection. ACS Nano. 2017;11(5):4428–4438.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28350437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nimal TR, Baranwal G, Bavya MC, Biswas R, Jayakumar R. Anti-staphylococcal activity of injectable nano tigecycline/chitosan-PRP composite hydrogel using Drosophila melanogaster model for infectious wounds. ACS Appl Mater Interfaces. 2016;8(34):22074–22083.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27508491</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deng Y, Kizer M, Rada M, et al.  Intracellular delivery of nano-materials via an inertial microfluidic cell hydroporator. Nano Lett. 2018;18(4):2705–2710.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29569926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaprelyants AS, Gottschal JC, Kell DB. Dormancy in non-sporulating bacteria. FEMS Microbiol Rev. 1993;10(3–4):271–286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8318260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anisimova YV, Gelperina SI, Peloquin CA, Heifets LB. Nanoparticles as antituberculosis drugs carriers: effect on activity against myco-bacterium tuberculosis in human monocyte-derived macrophages. J Nanopart Res. 2000;2(2):165–171.</Citation>
        </Reference>
        <Reference>
          <Citation>Lin PL, Flynn JL. Understanding latent tuberculosis: a moving target. J Immunol. 2010;185(1):15–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3311959</ArticleId>
            <ArticleId IdType="pubmed">20562268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma T, Shang BC, Tang H, et al.  Nano-hydroxyapatite/chitosan/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilms. J Biomater Sci Polym Ed. 2011;22(12):1669–1681.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21605505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pei Y, Mohamed MF, Seleem MN, Yeo Y. Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages. J Control Release. 2017;267:133–143.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28797580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mao C, Xie X, Liu X, et al.  The controlled drug release by pH-sensitive molecularly imprinted nanospheres for enhanced antibacterial activity. Mater Sci Eng C Mater Biol Appl. 2017;77:84–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28532100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xue Y, Xia X, Yu B, et al.  A green and facile method for the preparation of a pH-responsive alginate nanogel for subcellular delivery of doxorubicin. RSC Adv. 2015;5(90):73416–73423.</Citation>
        </Reference>
        <Reference>
          <Citation>Murakami M, Cabral H, Matsumoto Y, et al.  Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting. Sci Transl Med. 2011;3(64):ra2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21209412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ashby M, Petkova A, Hilpert K. Cationic antimicrobial peptides as potential new therapeutic agents in neonates and children: a review. Curr Opin Infect Dis. 2014;27(3):258–267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24722240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lopez Cascales JJ, Garro A, Porasso RD, Enriz RD. The dynamic action mechanism of small cationic antimicrobial peptides. Phys Chem Chem Phys. 2014;16(39):21694–21705.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25198294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>George S, Kishen A. Augmenting the antibiofilm efficacy of advanced noninvasive light activated disinfection with emulsified oxidizer and oxygen carrier. J Endod. 2008;34(9):1119–1123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18718378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>George S, Kishen A. Photophysical, photochemical, and photobiological characterization of methylene blue formulations for light-activated root canal disinfection. J Biomed Opt. 2007;12(3):034029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17614737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shrestha A, Cordova M, Kishen A. Photoactivated polycationic bioactive chitosan nanoparticles inactivate bacterial endotoxins. J Endod. 2015;41(5):686–691.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25637193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang Y, Zhang J, Chen W, et al.  Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection. J Control Release. 2017;263:185–191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5503807</ArticleId>
            <ArticleId IdType="pubmed">28087406</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
